SCHEMBL5577966

SCHEMBL5577966

Cc1ncn(-c2n[nH]c3nc(N)sc23)c1-c1ccccc1Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.35
MYC P01106 1/20 0.35
WDR5 P61964 1/20 0.35
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TYK2 P29597 2/20 0.32
JAK2 O60674 1/20 0.32
JAK1 P23458 1/20 0.32
JAK3 P52333 1/20 0.32
PDE2A O00408 2/20 0.31
POLB P06746 1/20 0.31
KMT2A Q03164 1/20 0.31
MAPK14 Q16539 1/20 0.31
PDE10A Q9Y233 1/20 0.31
LIMK1 P53667 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5577959 0.85 JAK2 (0.35) HSD11B1ALDH1A1HSD17B10NPC1RAB9A
SCHEMBL14454988 0.80 NPC1 (0.46) NPC1RAB9ATYK2JAK3KMT2A
SCHEMBL5577941 0.80 HSD11B1 (0.40) HSD11B1MYCWDR5ALDH1A1KDM4E
SCHEMBL4753611 0.78 GPBAR1 (0.39) HSD11B1MYCWDR5ALDH1A1KDM4E
SCHEMBL3500820 0.73 MYC (0.50) MYCWDR5ALDH1A1KDM4EHPGD
SCHEMBL14454993 0.69 CDC7 (0.34)
SCHEMBL5577958 0.66 GPBAR1 (0.38) HSD11B1ALDH1A1KDM4EHSD17B10NPC1
SCHEMBL5577939 0.65 HSD11B1 (0.36) HSD11B1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL5578054 0.65 SMN1; SMN2 (0.30) SMN1; SMN2
SCHEMBL5577951 0.65 GPBAR1 (0.39) HSD11B1HPGDNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators SGX PHARMACEUTICALS, INC. (US) 2007-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070173488-A1 Pyrazolothiazole Protein Kinase Modulators MAP4K2, MAP4K5, MAP4K3 HSD11B1 3411/4885MYC 617/4885WDR5 1797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.